Thomas K. Equels
CEO & President at AIM ImmunoTech Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: AIM ImmunoTech Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AIM ImmunoTech Inc. December 17, 202451.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 11, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +35,000 | $0.15 | $5,215 |
| Nov 10, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +39,000 | $0.14 | $5,382 |
| Nov 9, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +31,298 | $0.16 | $5,070 |
| Nov 6, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +20,299 | $0.16 | $3,167 |
| Nov 6, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +12,751 | $0.16 | $2,015 |
| Oct 23, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +31,675 | $0.16 | $5,068 |
| Oct 22, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +31,250 | $0.16 | $5,094 |
| Sep 17, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +24,000 | $0.21 | $5,040 |
| Sep 16, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +11,000 | $0.21 | $2,310 |
| Sep 15, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +22,000 | $0.22 | $4,840 |
| Sep 14, 2026 | AIM ImmunoTech Inc. | Open-market purchase | +5,900 | $0.22 | $1,298 |
| Mar 12, 2026 | AIM ImmunoTech Inc. | Derivative conversion | +25,000 | — | — |
| Jun 13, 2025 | AIM ImmunoTech Inc. | Open-market purchase | +107 | $7.70 | $824 |
| Jun 12, 2025 | AIM ImmunoTech Inc. | Open-market purchase | +103 | $8.70 | $896 |
| Apr 11, 2025 | AIM ImmunoTech Inc. | Open-market purchase | +1,968,504 | $0.03 | $59,055 |
Questions about Thomas K. Equels
What boards is Thomas K. Equels on?
Thomas K. Equels sits on the board of AIM ImmunoTech Inc.
What company is Thomas K. Equels the CEO of?
Thomas K. Equels is CEO & President of AIM ImmunoTech Inc.
How long has Thomas K. Equels served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.